bufalin has been researched along with Extravascular Hemolysis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Chen, P; Shi, F; Tang, L; Wang, Y; Xu, Y; Zheng, M | 1 |
1 other study(ies) available for bufalin and Extravascular Hemolysis
Article | Year |
---|---|
Tumor-Targeted Delivery of Bufalin-Loaded Modified Albumin-Polymer Hybrid for Enhanced Antitumor Therapy and Attenuated Hemolysis Toxicity and Cardiotoxicity.
Topics: Animals; Antineoplastic Agents; Bufanolides; Cardiotoxicity; Cell Death; Drug Carriers; Hemolysis; Hep G2 Cells; Humans; Nanoparticles; Neoplasms; Particle Size; Polymers; Serum Albumin, Bovine | 2021 |